Adverse Gastrointestinal Effects of Mycophenolate Mofetil
Top Cited Papers
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 24 (9), 645-663
- https://doi.org/10.2165/00002018-200124090-00002
Abstract
Mycophenolate mofetil (MMF) is a relatively new immunosuppressive drug. It inhibits inosine monophosphate dehydrogenase, a key enzyme in the de novopathway of purine synthesis, and thus causes...Keywords
This publication has 122 references indexed in Scilit:
- Cytomegalovirus Infection and Abdominal Pain with Mycophenolate MofetilDrug Safety, 2001
- Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal painAmerican Journal of Kidney Diseases, 1999
- MYCOPHENOLATE MOFETIL MONOTHERAPY IN STABLE LIVER TRANSPLANT PATIENTS WITH CYCLOSPORINE-INDUCED RENAL IMPAIRMENTTransplantation, 1999
- Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients-a multicentre studyNephrology Dialysis Transplantation, 1999
- Mycophenolate mofetil (Cellcept)Expert Opinion on Investigational Drugs, 1998
- STEROID WITHDRAWAL IN MYCOPHENOLATE MOFETIL-TREATED RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997
- Mycophenolate MofetilDrugs, 1996
- THE USE OF MYCOPHENOLATE MOFETIL (RS-61443) IN HUMAN HEART TRANSPLANT RECIPIENTSTransplantation, 1993
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- Comparison of Three Immunosuppressive Regimens in Cadaver Renal Transplantation: Long-Term Cyclosporine, Short-Term Cyclosporine Followed by Azathioprine and Prednisolone, and Azathioprine and Prednisolone without CyclosporineNew England Journal of Medicine, 1988